The program trains doctoral students to become independent researchers in Parkinson’s disease, dystonia, tremor and ataxia.
In The Conversation, Drs. Golde and DeKosky explain the new test, which shows high accuracy in detecting chemicals specific to Alzheimer’s.
Drs. Michael Jaffee and Glenn Smith are co-PIs on a UF Research Opportunity Seed Fund Award.
New, more diverse image better represents who is affected by Parkinson disease, and how.
Research led by Drs. Laura Ranum and Tao Zu is encouraging for future treatments for a type of ALS and several other neurological diseases.
New study led by Dr. Habibeh Khoshbouei, describes how impairment of dopamine transmission caused by manganese toxicity could potentially be blocked.
Drs. Linda Cottler and Sara Jo Nixon are members of UF's coordinating center team to lead national efforts to identify emerging drug abuse trends.
Dr. Valerie Joers will lead study seeking to identify novel approaches to treat Parkinson’s disease.
New study demonstrates an example of the brain’s ability to shift and utilize different neural circuits to perform a task in order to compensate for brain aging.
In JAMA Neurology editorial, Dr. Michael Jaffee and colleagues discuss REM sleep’s potential impact on general health.